NEURONOPATHIC LYSOSOMAL STORAGE DISEASES: CLINICAL AND PATHOLOGIC FINDINGS

被引:12
|
作者
Prada, Carlos E. [1 ,2 ]
Grabowski, Gregory A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA
[2] Cardiovasc Fdn Colombia, Ctr Genom Med & Metab, Floridablanca, Colombia
关键词
lysosomal storage diseases; neuronopathic disease; autophagy; inflammation; cell death; pathogenesis; NEURONAL CEROID-LIPOFUSCINOSES; ACID MALTASE DEFICIENCY; TAY-SACHS-DISEASE; GLOBOID-CELL LEUKODYSTROPHY; GAUCHER-DISEASE; SANDHOFF-DISEASE; KRABBE-DISEASE; PARKINSON-DISEASE; MOUSE MODEL; NEUROAXONAL DYSTROPHY;
D O I
10.1002/ddrr.1116
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The lysosomal-autophagocytic system diseases (LASDs) affect multiple body systems including the central nervous system (CNS). The progressive CNS pathology has its onset at different ages, leading to neurodegeneration and early death. Methods: Literature review provided insight into the current clinical neurological findings, phenotypic spectrum, and pathogenic mechanisms of LASDs with primary neurological involvement. Conclusions: CNS signs and symptoms are variable and related to the disease-specific underlying pathogenesis. LAS dysfunction leads to diverse global cellular consequences in the CNS ranging from specific axonal and dendritic abnormalities to neuronal death. Pathogenic mechanisms for disease progression vary from impaired autophagy, massive storage, regional involvement, to end-stage inflammation. Some of these features are also found in adult neurodegenerative disorders, for example, Parkinson's and Alzheimer's diseases. Lack of effective therapies is a significant unmet medical need. (C) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:226 / 246
页数:21
相关论文
共 50 条
  • [41] The rapidly evolving view of lysosomal storage diseases
    Parenti, Giancarlo
    Medina, Diego L.
    Ballabio, Andrea
    EMBO MOLECULAR MEDICINE, 2021, 13 (02)
  • [42] Highlights on Genomics Applications for Lysosomal Storage Diseases
    La Cognata, Valentina
    Guarnaccia, Maria
    Polizzi, Agata
    Ruggieri, Martino
    Cavallaro, Sebastiano
    CELLS, 2020, 9 (08) : 1 - 15
  • [43] Enzyme replacement therapies in lysosomal storage diseases
    Germain, D. P.
    Boucly, C.
    Carlier, R. Y.
    Caudron, E.
    Charlier, P.
    Colas, F.
    Jabbour, F.
    Martinez, V.
    Mokhtari, S.
    Orlikowski, D.
    Pellegrini, N.
    Perronne, C.
    Prigent, H.
    Rubinsztajn, R.
    Benistan, K.
    REVUE DE MEDECINE INTERNE, 2010, 31 : S279 - S291
  • [45] Clarifying lysosomal storage diseases
    Schultz, Mark L.
    Tecedor, Luis
    Chang, Michael
    Davidson, Beverly L.
    TRENDS IN NEUROSCIENCES, 2011, 34 (08) : 401 - 410
  • [46] Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem
    Macauley, Shannon L.
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2016, 13 : 639 - 648
  • [47] Storage problems in lysosomal diseases
    Heard, Jean Michel
    Bruyere, Julie
    Roy, Elise
    Bigou, Stephanie
    Ausseil, Jerome
    Vitry, Sandrine
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 1442 - 1447
  • [48] Lysosomal storage diseases in adults
    Stulnig, Thomas
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2019, 12 (01): : 2 - 6
  • [49] LYSOSOMAL STORAGE DISEASES IN ADULTS
    RAPOLA, J
    PATHOLOGY RESEARCH AND PRACTICE, 1994, 190 (08) : 759 - 766
  • [50] Aberrant Ca2+ handling in lysosomal storage disorders
    Kiselyov, Kirill
    Yamaguchi, Soichiro
    Lyons, Christopher W.
    Muallem, Shmuel
    CELL CALCIUM, 2010, 47 (02) : 103 - 111